Carregant...

Clinical use of the Oncotype DX genomic test to guide treatment decisions for patients with invasive breast cancer

Implementation of the Oncotype DX assay has led to a change in the manner in which chemotherapy is utilized in patients with early stage, estrogen receptor (ER)-positive, node-negative breast cancer; ensuring that patients at highest risk of recurrence are prescribed systemic treatment, while at the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Breast Cancer (Dove Med Press)
Autors principals: McVeigh, Terri P, Kerin, Michael J
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2017
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5459968/
https://ncbi.nlm.nih.gov/pubmed/28615971
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S109847
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!